1. Home
  2. UROY vs CMPS Comparison

UROY vs CMPS Comparison

Compare UROY & CMPS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Uranium Royalty Corp.

UROY

Uranium Royalty Corp.

HOLD

Current Price

$4.01

Market Cap

513.2M

Sector

N/A

ML Signal

HOLD

Logo COMPASS Pathways Plc American Depository Shares

CMPS

COMPASS Pathways Plc American Depository Shares

HOLD

Current Price

$5.85

Market Cap

598.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
UROY
CMPS
Founded
2017
2020
Country
Canada
United Kingdom
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
513.2M
598.7M
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
UROY
CMPS
Price
$4.01
$5.85
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
8
Target Price
$4.50
$16.43
AVG Volume (30 Days)
2.4M
1.5M
Earning Date
12-12-2025
11-04-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$35,266,447.00
N/A
Revenue This Year
$195.97
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
14.29
N/A
52 Week Low
$1.43
$2.25
52 Week High
$5.37
$7.09

Technical Indicators

Market Signals
Indicator
UROY
CMPS
Relative Strength Index (RSI) 57.09 55.39
Support Level $3.63 $4.90
Resistance Level $3.87 $5.57
Average True Range (ATR) 0.20 0.35
MACD 0.06 0.06
Stochastic Oscillator 95.60 93.81

Price Performance

Historical Comparison
UROY
CMPS

About UROY Uranium Royalty Corp.

Uranium Royalty Corp is focused on gaining exposure to uranium prices by making investments in uranium interests, including royalties, streams, debt and equity investments in uranium companies, and through holdings of physical uranium. The company operates in a single segment that is acquiring and assembling a portfolio of royalties, investing in companies with exposure to uranium and physical uranium. The Company also engages in the purchase and sale of physical uranium.

About CMPS COMPASS Pathways Plc American Depository Shares

Compass Pathways PLC is a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health. The company is motivated by the need to find ways to help and empower people suffering with mental health challenges who are not helped by existing therapies and are pioneering the development of a new model of psilocybin therapy, in which psilocybin is administered in conjunction with psychological support. Its focus is on treatment-resistant depression, or TRD, a subset of major depressive disorder, or MDD, comprising patients who are inadequately served by the treatment paradigm. It has developed a proprietary, high-purity polymorphic crystalline formulation of psilocybin, COMP360.

Share on Social Networks: